AVAH
Aveanna Healthcare Holdings Inc. (AVAH) 10Y Growth Potential Analysis (2026)
Overall Score
Growth
Revenue base remains solid with revenue per share at 11.95 and asset turnover at 1.24, supporting steady top-line productivity.
Profitability is healthy with gross margin at 32.0% and operating margin at 11.1%, indicating room for continued earnings growth.
Return on invested capital is 16.8%, suggesting the business is still compounding capital at an acceptable rate.
Profitability
Gross margin is 32.0% and EBITDA margin is 11.5%, showing a reasonably efficient operating model.
Return on assets is 13.0% and return on equity is 150.2%, reflecting strong accounting profitability.
Free cash flow conversion is high, with free cash flow operating cash flow ratio at 98.4%, indicating most operating cash flow is turning into free cash flow.
Financial Health
Liquidity is adequate but not strong, with current ratio at 1.16 and cash ratio at 0.24.
Leverage remains elevated, with debt-to-equity at 4.67 and net debt to EBITDA at 4.16.
Interest coverage is only 2.32x, leaving limited cushion if operating performance weakens.
Valuation
Valuation looks reasonable on earnings, with P/E at 8.1 and earnings yield at 11.8%.
EV/Sales of 1.37 and price-to-sales of 0.90 suggest the market is not pricing in aggressive growth.
Free cash flow valuation is less cheap than earnings-based multiples imply, with price to free cash flow at 17.1.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Aveanna Healthcare Holdings Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

